FindTrial
Sign In

A systematic review and meta-analysis of the usefulness of de-escalation in hospital acquired pneumonia

A systematic review and meta-analysis of the usefulness of de-escalation in hospital acquired pneumonia - A systematic review and meta-analysis of the usefulness of de-escalation in hospital acquired pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049008
Enrollment
Unknown
Registered
2022-09-24
Start date
2022-09-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hospital-acquired pneumonia

Interventions

None listed

Sponsors

Systematic review team of Japanese clinical practice guidelines of pneumonia, 2022
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with hospital-acquired pneumonia are defined by the 2017 JRS guidelines or hospital-acquired pneumonia is defined by the 2016 ATS/IDSA guidelines.

Exclusion criteria

Exclusion criteria: Pediatric patients

Design outcomes

Primary

MeasureTime frame
The cure rate of pneumonia—

Secondary

MeasureTime frame
Mortality assessed in each study, the rate of readmission, the occurrence of drug-resistant pathogens, duration of hospital stay, the frequency of adverse events, medical expenses.—

Countries

Japan

Contacts

Public ContactNaoki Iwanaga

Nagasaki University Hospital Department of Respiratory Medicine

niwanaga@nagasaki-u.ac.jp095-819-7273

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026